We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.53B
AUM Growth
+$123M
Cap. Flow
+$28.7M
Cap. Flow %
1.88%
Top 10 Hldgs %
38.1%
Holding
287
New
28
Increased
140
Reduced
72
Closed
13

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$56.8M
2
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$47.5M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$32.4M
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$28M
5
SPSM icon
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
+$26.7M

Top Sells

Rank Stock Value
1
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$215M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$17.6M
3
EXPE icon
Expedia Group
EXPE
+$7.98M
4
WTMF icon
WisdomTree Managed Futures Strategy Fund
WTMF
+$5.58M
5
KLAC icon
KLA
KLAC
+$5.27M

Sector Composition

Rank Sector Weight
1 Technology 11.29%
2 Healthcare 7.76%
3 Industrials 6.08%
4 Consumer Discretionary 4.75%
5 Financials 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVA icon
251
Innoviva
INVA
$1.57B
$187K 0.01%
+13,200
New +$162K
INFY icon
252
Infosys
INFY
$48.4B
$157K 0.01%
15,260
+2,080
+16% +$20.9K
EYPT icon
253
EyePoint Inc
EYPT
$1.08B
$153K 0.01%
+9,850
New +$176K
CALA
254
DELISTED
Calithera Biosciences, Inc
CALA
$144K 0.01%
1,265
+250
+25% +$18.8K
PBYI icon
255
Puma Biotechnology
PBYI
$402M
$143K 0.01%
16,300
+300
+2% +$2.48K
NAK
256
Northern Dynasty Minerals
NAK
$779M
$117K 0.01%
272,215
-25,000
-8% -$13.1K
VBIV
257
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$110K 0.01%
+2,657
New +$58.2K
LJPC
258
DELISTED
La Jolla Pharmaceutical Company
LJPC
$96K 0.01%
+24,500
New +$145K
ASX icon
259
ASE Group
ASX
$76.5B
$72K ﹤0.01%
13,028
+232
+2% +$1.19K
GNW icon
260
Genworth Financial
GNW
$3.81B
$58K ﹤0.01%
13,225
– –
AGRX
261
DELISTED
Agile Therapeutics
AGRX
$50K ﹤0.01%
+10
New +$34.9K
AAC
262
DELISTED
AAC Holdings
AAC
$33K ﹤0.01%
60,454
– –
AVEO
263
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$14K ﹤0.01%
2,260
– –
ALGN icon
264
Align Technology
ALGN
$12.4B
– –
-1,300
Closed -$235K
CAT icon
265
Caterpillar
CAT
$373B
– –
-1,820
Closed -$230K
CNP icon
266
CenterPoint Energy
CNP
$27.8B
– –
-7,010
Closed -$212K
DLTR icon
267
Dollar Tree
DLTR
$24.7B
– –
-1,797
Closed -$205K
EMB icon
268
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
– –
-5,535
Closed -$627K
EXPE icon
269
Expedia Group
EXPE
$35.2B
– –
-59,346
Closed -$7.98M
LYG icon
270
Lloyds Banking Group
LYG
$90.7B
– –
-14,879
Closed -$39K
SHV icon
271
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
– –
-1,947,516
Closed -$215M
VOO icon
272
Vanguard S&P 500 ETF
VOO
$972B
– –
-749
Closed -$204K
WTMF icon
273
WisdomTree Managed Futures Strategy Fund
WTMF
$245M
– –
-146,678
Closed -$5.58M
XLP icon
274
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
– –
-286,511
Closed -$17.6M
MDCO
275
DELISTED
Medicines Co
MDCO
– –
-5,000
Closed -$250K
8 9 10
11
12

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Grimes & Company's Q4 2019 Portfolio in Review

As of Q4 2019, Grimes & Company held 287 positions worth $1.53B, up 8.7% from $1.4B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Grimes & Company's Q4 2019 filing shows 28 new, 140 increased, 72 reduced and 13 closed positions. Its largest new stake was TripAdvisor: 216,616 shares worth $6.58M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $215M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Industrials.

  • Grimes & Company's largest Q4 2019 buy was TripAdvisor: 216,616 shares worth $6.58M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q4 2019, an estimated $56.8M increase.
  • Grimes & Company's biggest Q4 2019 reduction was KLA, cutting an estimated $5.27M.
  • Grimes & Company fully exited iShares 0-1 Year Treasury Bond ETF in Q4 2019, selling an estimated $215M.
  • Grimes & Company's ten largest holdings make up 38% of its $1.53B portfolio in Q4 2019.
  • Grimes & Company opened 28 new positions and closed 13 in Q4 2019.
  • Grimes & Company's portfolio value rose 8.7% quarter-over-quarter to $1.53B.

Based on Grimes & Company's 13F filing for Q4 2019, filed 5 Feb 2020.